Metolazone Suspended Phase 4 Trials for Coronavirus Disease 2019 (COVID‑19) / High Blood Pressure (Hypertension) Prevention

Indications	Status	Purpose	Phase
DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19)) DBCOND0040789 (High Blood Pressure (Hypertension))	Suspended	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT04330300	Coronavirus (COVID-19) ACEi/ARB Investigation	Amlodipine (DB00381) Angiotensin II (DB11842) Benazepril (DB00542) Bendroflumethiazide (DB00436) Calcium (DB01373) Candesartan (DB13919) Captopril (DB01197) Chlorothiazide (DB00880) Chlorthalidone (DB00310) Diltiazem (DB00343) Enalapril (DB00584) Eprosartan (DB00876) Felodipine (DB01023) Fosinopril (DB00492) Hydrochlorothiazide (DB00999) Indapamide (DB00808) Irbesartan (DB01029) Lisinopril (DB00722) Losartan (DB00678) Metolazone (DB00524) Nicardipine (DB00622) Nifedipine (DB01115) Nimodipine (DB00393) Nitrendipine (DB01054) Olmesartan (DB00275) Perindopril (DB00790) Quinapril (DB00881) Ramipril (DB00178) Telmisartan (DB00966) Trandolapril (DB00519) Valsartan (DB00177) Verapamil (DB00661)